| 1 |
2020/08/07 |
Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) |
CELL BIOTECH CO ., LTD |
| 2 |
2020/07/29 |
[Revised]Decision on Entering into Trust Contract for Acquisition of Treasury Stocks(연장결정) |
CELL BIOTECH CO ., LTD |
| 3 |
2020/05/08 |
Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) |
CELL BIOTECH CO ., LTD |
| 4 |
2020/03/26 |
Outcome of Annual Shareholders` Meeting |
CELL BIOTECH CO ., LTD |
| 5 |
2020/03/18 |
Submission of Audit Report |
CELL BIOTECH CO ., LTD |
| 6 |
2020/03/10 |
Reporting reasons for holding general shareholders' meeting on the most concentrated date |
CELL BIOTECH CO ., LTD |
| 7 |
2020/02/25 |
[Revised]Decision on Cash Dividend and Dividend in Kind |
CELL BIOTECH CO ., LTD |
| 8 |
2020/02/25 |
Decision on Calling Shareholders` Meeting |
CELL BIOTECH CO ., LTD |
| 9 |
2020/02/25 |
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) |
CELL BIOTECH CO ., LTD |
| 10 |
2020/02/14 |
Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) |
CELL BIOTECH CO ., LTD |
